So much hype here. A 50k share purchase could push this up to 1.5c. Despite all the positive sentiment no one actually believes these guys can improve revenues. It’s a hold knowing that it can’t dip below 1c thanks to the buy back in place.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
